Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Further Insights in 5-phenyl-2-[2-(1-piperidinylcarbonyl) Phenyl]-2,3- dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones, a Recently Disclosed Class of Neuropeptide S Antagonists

Author(s): Adelheid Roth, Anna Maria Capelli, Raffaele Longhi, Federica Tonelli, Luca Tarsi, Dino Montanari, Giorgio Bonanomi, Matteo Biagetti, Emilio Merlo-Pich, Gabriele Costantino, Angelo Giacometti, Romano Di Fabio, Angela Worby, Fabrizio Micheli, Elisa Della Turca, Gian Paolo Vallerini, Chiara Pecchini and Marco Mor

Volume 10, Issue 5, 2013

Page: [396 - 401] Pages: 6

DOI: 10.2174/1570180811310050005

Price: $65

Abstract

In this paper, a recently reported series of NPS antagonists is further expanded and biologically evaluated. The ligand efficiency and ADMET score concepts were then applied to the newly disclosed 5-phenyl-2-[2-(1-piperidinylcarbonyl) phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones, to limit the SAR exploration. Important pharmacophoric features were identified suggesting potential way forward for the identification of further developable templates.

Keywords: ADMET score, Ligand efficiency, NPS antagonists, Pharmacophore features


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy